• Cancel
    Date:2018-08
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=219

    Missfresh Inc., a mobile retailer of fresh food, announced today that it had completed a $100 million Series C financing led by the management fund under Lenovo Capital, the direct investment arm of Lenovo Group, and ZSVC. Its existing investors Tencent,

  • Cancel
    Date:2018-07

    CEC Capital Served as Exclusive Financial Advisor

  • Cancel
    Date:2018-06

    CEC Capital Served as Exclusive Financial Advisor

  • Cancel
    Date:2018-06

    CEC Capital Served as Exclusive Financial Advisor

  • Cancel
    Date:2018-05

    CEC Capital Served as Exclusive Financial Advisor

  • Cancel
    Date:2018-04
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=367

    AutocloudPro, an auto parts supply chain service company, announced that it had completed Series C financing of RMB 500 million. The round was led by UCAR Capital. This was one of the largest capital raises in the industry.

  • Cancel
    Date:2018-04
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=368

    April 25, 2018- RENRENCHE.COM, a leading Chinese trading platform for used cars, announced that it had completed a new round of financing in the amount of $300 million. The round was led by Goldman Sachs’SSG group, with participation from Tencent and Didi, two internet behemoths in China. CEC Capital served as the Exclusive Financial Advisor to RENRENCHE in this transaction.

  • Cancel
    Date:2018-04
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=369

    Innovative Cellular Therapeutics (ICT) announced that the company had completed its Series B financing of RMB 180 million. Investors in this new round included Volcanics Venture, GTJA Investment Group, SBCVC, Dunhou Capital and Withtruth Capital. The com

  • Cancel
    Date:2018-03
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=352

    EYEGOOD OPHTHALMIC, chain brand of domestic leading ophthalmic hospital, announced that the company has completed $40 million series B financing led by CDH Investments. This is a new round of financing after series A by OrbiMed in 2015.